APA (7th ed.) Citation

YT, S., SF, T., CT, L., CY, L., JS, T., CC, L., & CW, K. (2025). Comparative Survival Analysis of Anti-Angiogenic Agent Plus Immunochemotherapy in NSCLC Patients After Frontline EGFR-TKI Treatment: A Retrospective Cohort Study. The Kaohsiung journal of medical sciences, 41(7), e70023. https://doi.org/10.1002/kjm2.70023

Chicago Style (17th ed.) Citation

YT, Su, Tey SF, Lee CT, Lin CY, Tsai JS, Lin CC, and Kuo CW. "Comparative Survival Analysis of Anti-Angiogenic Agent Plus Immunochemotherapy in NSCLC Patients After Frontline EGFR-TKI Treatment: A Retrospective Cohort Study." The Kaohsiung Journal of Medical Sciences 41, no. 7 (2025): e70023. https://doi.org/10.1002/kjm2.70023.

MLA (9th ed.) Citation

YT, Su, et al. "Comparative Survival Analysis of Anti-Angiogenic Agent Plus Immunochemotherapy in NSCLC Patients After Frontline EGFR-TKI Treatment: A Retrospective Cohort Study." The Kaohsiung Journal of Medical Sciences, vol. 41, no. 7, 2025, p. e70023, https://doi.org/10.1002/kjm2.70023.